The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

"Chronic hepatitis delta is the most aggressive form of viral hepatitis and the lack of approved treatments in the United ...

A new study conducted during the first-ever reactive use of the Hecolin vaccine in South Sudan showed that a two-dose regimen ...

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

Having peers facilitate virtual visits may lead to many more patients with hepatitis C receiving treatment and clearing the ...

Chennai: Deaths due to viral hepatitis, which causes inflammation and damage to the liver, surpassed AIDS, tuberculosis, and malaria nearly a decade a.

Egypt's Minister of Health and Population Khaled Abdel Ghaffar announced that the country has met the regional target for ...

FDA tackles viral contamination in berries with new safety measures. Learn risks, prevention, and consumer tips for berry ...